These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5154124)

  • 21. Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients.
    Knudsen P; Hansen LB; Auken G; Waehrens J; Højholdt K; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():15-28. PubMed ID: 3907278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of prolonged-action neuroleptics on rehospitalization of psychotic patients in a regional practice].
    Richou H
    Ann Med Psychol (Paris); 1975 Jul; 2(2):399-402. PubMed ID: 9894
    [No Abstract]   [Full Text] [Related]  

  • 23. Dose-response relationships of perphenazine in the treatment of acute psychoses.
    Hansen LB; Larsen NE; Gulmann N
    Psychopharmacology (Berl); 1982; 78(2):112-5. PubMed ID: 6817364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients.
    Hanlon TE; Schoenrich C; Freinek W; Turek I; Kurland AA
    Psychopharmacologia; 1966; 9(4):328-39. PubMed ID: 4874349
    [No Abstract]   [Full Text] [Related]  

  • 25. Perphenazine decanoate in sesame oil vs. perphenazine enanthate in sesame oil: a comparative study of pharmacokinetic properties and some clinical implications.
    Knudsen P; Hansen LB; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():11-4. PubMed ID: 3865500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical treatment of chronic psychoses with flupenthixol-decanoate (Fluanxol-Depot)].
    Gross H; Kaltenbäck E
    Wien Klin Wochenschr; 1972 Feb; 84(5):80-4. PubMed ID: 5015880
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative characteristics of the effect of melipramine on the bio-electric activity of the brain in patients with circular depression and paranoid schizophrenia].
    Burmismrova ZD; Smulevich AB; Faĭgenberg IM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1375-80. PubMed ID: 5705721
    [No Abstract]   [Full Text] [Related]  

  • 28. The differential response to parenteral chlorpromazine and mesoridazine in psychotic patients.
    Brauzer B; Goldstein BJ
    J Clin Pharmacol J New Drugs; 1970; 10(2):126-31. PubMed ID: 4906541
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate].
    Salvesen C; Vaksdal K
    Tidsskr Nor Laegeforen; 1973 Aug; 93(24):1699-703. PubMed ID: 4149082
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
    Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M
    Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical comparison of methophenazine and perphenazine in schizophrenia. A controlled study. Effects on the photomyoclonic threshold].
    Náhunek K; Svestka J; Misurec J
    Act Nerv Super (Praha); 1967 Nov; 9(4):404-5. PubMed ID: 4889075
    [No Abstract]   [Full Text] [Related]  

  • 32. Loxapine versus perphenazine in psychotic patients. A double-blind, randomized, multicentre trial.
    Fruensgaard K; Wollenberg J; Hansen KM; Fensbo C; Sihm F
    Curr Med Res Opin; 1978; 5(8):601-7. PubMed ID: 361345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of perphenazine in psychiatric emergencies: the concept of chemical restraint.
    Fann WE; Linton PH
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):478-82. PubMed ID: 4629310
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetic implications of different oil vehicles used in depot neuroleptic treatment.
    Knudsen P; Hansen LB; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():7-10. PubMed ID: 3865501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low dose perphenazine and levodopa/carbidopa therapy in a patient with Parkinsonism and a psychotic illness.
    Hale MS; Bellizzi J
    J Nerv Ment Dis; 1980 May; 168(5):312-4. PubMed ID: 7365497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)].
    Eufe R; Wegener G
    Nervenarzt; 1979 Aug; 50(8):534-9. PubMed ID: 394015
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasma catecholamine metabolites and treatment response at neuroleptic steady state.
    Bowers MB; Swigar ME; Jatlow PI; Hoffman FJ
    Biol Psychiatry; 1989 Mar; 25(6):734-8. PubMed ID: 2923935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparative effectiveness of eight phenothiazines.
    Hanlon TE; Michaux MH; Ota KY; Shaffer JW; Kurland AA
    Psychopharmacologia; 1965 Feb; 7(2):89-106. PubMed ID: 5318926
    [No Abstract]   [Full Text] [Related]  

  • 39. The computer analyzes two psychotherapeutic agents in anxiety-depressed states.
    Falk MA
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):488-99. PubMed ID: 4198312
    [No Abstract]   [Full Text] [Related]  

  • 40. Intramuscular preparations of antipsychotics: uses and relevance in clinical practice.
    Altamura AC; Sassella F; Santini A; Montresor C; Fumagalli S; Mundo E
    Drugs; 2003; 63(5):493-512. PubMed ID: 12600227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.